Avadel Pharmaceuticals Plc Stock Price Prediction
| AVDL Stock | USD 7.95 0.26 3.38% |
Oversold Vs Overbought
28
Oversold | Overbought |
EPS Estimate Next Quarter (0.07) | EPS Estimate Current Year (0.46) | EPS Estimate Next Year 0.68 | Wall Street Target Price 24.7 | EPS Estimate Current Quarter (0.16) |
Using Avadel Pharmaceuticals hype-based prediction, you can estimate the value of Avadel Pharmaceuticals PLC from the perspective of Avadel Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Avadel Pharmaceuticals using Avadel Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Avadel using crowd psychology based on the activity and movement of Avadel Pharmaceuticals' stock price.
Avadel Pharmaceuticals Short Interest
An investor who is long Avadel Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about Avadel Pharmaceuticals and may potentially protect profits, hedge Avadel Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA 15.2769 | Short Percent 0.121 | Short Ratio 12.45 | Shares Short Prior Month 11.8 M | 50 Day MA 13.672 |
Avadel Pharmaceuticals Hype to Price Pattern
Investor biases related to Avadel Pharmaceuticals' public news can be used to forecast risks associated with an investment in Avadel. The trend in average sentiment can be used to explain how an investor holding Avadel can time the market purely based on public headlines and social activities around Avadel Pharmaceuticals PLC. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Avadel Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Avadel Pharmaceuticals.
Avadel Pharmaceuticals Implied Volatility | 1.73 |
Avadel Pharmaceuticals' implied volatility exposes the market's sentiment of Avadel Pharmaceuticals PLC stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Avadel Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Avadel Pharmaceuticals stock will not fluctuate a lot when Avadel Pharmaceuticals' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in Avadel Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Avadel because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Avadel Pharmaceuticals after-hype prediction price | USD 7.69 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Avadel contract
Based on the Rule 16, the options market is currently suggesting that Avadel Pharmaceuticals PLC will have an average daily up or down price movement of about 0.11% per day over the life of the 2025-03-21 option contract. With Avadel Pharmaceuticals trading at USD 7.95, that is roughly USD 0.008596 . If you think that the market is fully incorporating Avadel Pharmaceuticals' daily price movement you should consider acquiring Avadel Pharmaceuticals PLC options at the current volatility level of 1.73%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Avadel |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Avadel Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Avadel Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Avadel Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Avadel Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Avadel Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Avadel Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Avadel Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Avadel Pharmaceuticals' historical news coverage. Avadel Pharmaceuticals' after-hype downside and upside margins for the prediction period are 2.40 and 12.98, respectively. We have considered Avadel Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Avadel Pharmaceuticals is moderately volatile at this time. Analysis and calculation of next after-hype price of Avadel Pharmaceuticals is based on 3 months time horizon.
Avadel Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Avadel Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Avadel Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Avadel Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.94 | 5.29 | 0.17 | 0.24 | 8 Events / Month | 8 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
7.95 | 7.69 | 0.00 |
|
Avadel Pharmaceuticals Hype Timeline
Avadel Pharmaceuticals is presently traded for 7.95. The entity has historical hype elasticity of 0.17, and average elasticity to hype of competition of -0.24. Avadel is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is presently at -0.94%. %. The volatility of related hype on Avadel Pharmaceuticals is about 2076.91%, with the expected price after the next announcement by competition of 7.71. About 80.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 0.07. Avadel Pharmaceuticals recorded a loss per share of 1.09. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Avadel Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Avadel Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Avadel Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Avadel Pharmaceuticals' future price movements. Getting to know how Avadel Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Avadel Pharmaceuticals may potentially react to the hype associated with one of its peers.
Avadel Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Avadel price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Avadel using various technical indicators. When you analyze Avadel charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Avadel Pharmaceuticals Predictive Indicators
The successful prediction of Avadel Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Avadel Pharmaceuticals PLC, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Avadel Pharmaceuticals based on analysis of Avadel Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Avadel Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Avadel Pharmaceuticals's related companies. | 2024 | 2025 (projected) | Payables Turnover | 0.0666 | 0.0633 | Days Of Inventory On Hand | 4.0K | 4.2K |
Story Coverage note for Avadel Pharmaceuticals
The number of cover stories for Avadel Pharmaceuticals depends on current market conditions and Avadel Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Avadel Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Avadel Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Avadel Pharmaceuticals Short Properties
Avadel Pharmaceuticals' future price predictability will typically decrease when Avadel Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Avadel Pharmaceuticals PLC often depends not only on the future outlook of the potential Avadel Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Avadel Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 80.2 M | |
| Cash And Short Term Investments | 105.1 M |
Check out Avadel Pharmaceuticals Basic Forecasting Models to cross-verify your projections. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avadel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.09) | Revenue Per Share | Quarterly Revenue Growth 26.743 | Return On Assets | Return On Equity |
The market value of Avadel Pharmaceuticals is measured differently than its book value, which is the value of Avadel that is recorded on the company's balance sheet. Investors also form their own opinion of Avadel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Avadel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avadel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Avadel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avadel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avadel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avadel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.